There are marked differences in survival between uterine sarcoma types. Leiomyosarcomas and endometrial stromal sarcomas can be divided into different groups.

Implications of all the available evidence It is possible to utilise deep learning to develop biomarkers for automatic prediction of patient outcome directly from conventional histopathology images. In colorectal cancer, the marker was found to be a clinically useful prognostic marker in analysis of a large series of patients who received consistent, modern cancer treatment.